Onabotulinumtoxina for the treatment of new daily persistent headache: an open label study

ID Number R-13-002

Principal Investigator(s)

Department(s) or Division(s)


The purpose of this study is to evaluate the effect of OnabotulinumtoxinA (Botox®) on the number of headache days in patients with New Daily Persistent Headache (NDPH). NDPH is a benign form of chronic daily headache that is often difficult to treat. OnabotulinumtoxinA will be injected into specific muscles of the head and neck area to determine if it will reduce or relieve headaches.

Contact Information
Iris Harris
(212) 523-2381

Recruiting Patients: Yes